UNVERIFIEDSingle Source
STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies
Stat News|9/4/2026
B
Biotech
959 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
19
Activity (Last 30 Days)
1
2
4
3
3
4
2
2026-08-192026-09-04
Top Publishers
Stat News18 stories
BioSpace1 stories
Stories (Latest First)
UNVERIFIEDSingle Source
STAT+: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder
Stat News|9/3/2026
UNVERIFIEDSingle Source
STAT+: Seattle scientists launch $95 million AI biology effort
Stat News|9/3/2026
UNVERIFIEDSingle Source
STAT+: Abivax has still not been acquired. What’s going on?
Stat News|9/3/2026
UNVERIFIEDSingle Source
Opinion: STAT+: A surprising bright spot at the FDA on regulating unproven stem cells
Stat News|9/3/2026
UNVERIFIEDSingle Source
STAT+: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial
Stat News|9/2/2026
UNVERIFIEDSingle Source
STAT+: ARPA-H funds biotechs working on custom RNA therapies
Stat News|9/2/2026
UNVERIFIEDSingle Source
Battelle Researchers Demonstrate Biotech Breakthrough for Rare Earth Element Separation
BioSpace|9/2/2026
UNVERIFIEDSingle Source
STAT+: 5 burning questions on Trump’s latest deals with drugmakers
Stat News|9/1/2026
UNVERIFIEDSingle Source
STAT+: Novartis gets multiple sclerosis win with BTK inhibitor
Stat News|9/1/2026
UNVERIFIEDSingle Source
STAT+: Will House delay Trump plan to politicize NIH grants?
Stat News|9/1/2026
UNVERIFIEDSingle Source
Trump strikes nine more deals with drugmakers to lower prices
Stat News|8/31/2026
UNVERIFIEDSingle Source
STAT+: Can a pregnancy hormone steer a cardiovascular treatment?
Stat News|8/31/2026
UNVERIFIEDSingle Source
STAT+: Cadre of radiopharmaceuticals experts pushes the bounds in cancer therapy
Stat News|8/31/2026
UNVERIFIEDSingle Source
STAT+: After a rough stretch, mRNA gets a boost — at least for now
Stat News|8/31/2026
UNVERIFIEDSingle Source
STAT+: FDA approves Protagonist and Takeda’s drug for rare blood cancer
Stat News|8/30/2026
UNVERIFIEDSingle Source
STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua
Stat News|8/30/2026
UNVERIFIEDSingle Source
STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Stat News|8/19/2026